Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

February 14, 2018

New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 23, 2016

Since 2006, Doctors Without Borders/Médecins Sans Frontières (MSF) has been providing ambulatory medical and psychosocial care for people in Mumbai living with drug-resistant tuberculosis (DRTB), HIV, hepatitis C, or a combination of these diseases. The majority of the patients are HIV positive who require second or third line treatment. Narendra* is one of only two percent of drug-resistant TB patients in need that have access to these new drugs.

May 15, 2014

 

Although tuberculosis (TB) is preventable and curable, it is the second-biggest infectious disease killer behind HIV and claims nearly 1.3 million lives each year.

The spread of drug-resistant strains of the disease is increasingly recognized as a public health emergency. Drug-resistant tuberculosis (DR-TB) is an umbrella term that refers to tuberculosis strains which resist the drugs routinely used to treat conventional TB.

October 30, 2013

In the mountainous region of Nagaland, northeast India, Doctors Without Borders/Médecins Sans Frontières (MSF) is working with local groups and health authorities to treat people with drug-resistant tuberculosis (DR-TB), a form of the disease that does not respond to the two main drugs used to treat TB. The two-year regimen for treating DR-TB is extremely arduous and can cause patients to become blind or deaf and can cause organ failure. MSF is calling for better diagnosis and treatment for DR-TB. Support the Test Me, Treat Me DR-TB Manifesto. Sign now at http://msfaccess.org/TBmanifesto/.

March 22, 2012

Multidrug-resistant tuberculosis patient and TB&ME blogger Athong talks from India about the stigma he faces living with the disease. Read Athong's TB&ME blog here.

January 18, 2012

People living in tribal villages in central India are caught up in the conflict between Maoist rebels and government forces. Dr. Rebecca Cuthbert describes how MSF takes the clinics to them.

July 04, 2011

Real stories of people living with multidrug-resistant tuberculosis. Today's feature from Swaziland: "I do get a lot of emotional support from my family, but financially we are struggling."

February 23, 2011

The most widely used method to test patients for TB fails to identify the disease in about half of the cases. But a long-awaited new test is raising hopes that we will be able to identify TB more effectively, get patients on treatment faster, and help reign in this deadly epidemic.

March 24, 2010

MSF updates on Haiti, tuberculosis, Mali, Sri Lanka, and Kenya.